![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | LGALS12 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Lgals12 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of LGALS12 mRNA | CTD | PMID:20188158 | LGALS12 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of LGALS12 mRNA | CTD | PMID:28628672 | LGALS12 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of LGALS12 mRNA | CTD | PMID:27685785 | LGALS12 | Human | 4-hydroxyphenyl retinamide | decreases expression | ISO | Lgals12 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of LGALS12 mRNA | CTD | PMID:28973697 | LGALS12 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of LGALS12 mRNA | CTD | PMID:33167477 | LGALS12 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of LGALS12 exon | CTD | PMID:27901495 | LGALS12 | Human | bisphenol A | multiple interactions | ISO | Lgals12 (Mus musculus) | 6480464 | [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA] | CTD | PMID:27082013 | LGALS12 | Human | bisphenol A | increases expression | ISO | Lgals12 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of LGALS12 mRNA | CTD | PMID:36779543 | LGALS12 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of LGALS12 gene | CTD | PMID:31601247 | LGALS12 | Human | bisphenol A | increases expression | ISO | Lgals12 (Mus musculus) | 6480464 | bisphenol A results in increased expression of LGALS12 mRNA | CTD | PMID:38701888 | LGALS12 | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of LGALS12 mRNA | CTD | PMID:27685785 | LGALS12 | Human | bisphenol A | decreases expression | ISO | Lgals12 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of LGALS12 mRNA | CTD | PMID:25181051 | LGALS12 | Human | bisphenol A | affects expression | ISO | Lgals12 (Mus musculus) | 6480464 | bisphenol A affects the expression of LGALS12 mRNA | CTD | PMID:27082013 | LGALS12 | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of LGALS12 mRNA | CTD | PMID:27594783 | LGALS12 | Human | clothianidin | increases expression | EXP | | 6480464 | clothianidin results in increased expression of LGALS12 mRNA | CTD | PMID:31626844 | LGALS12 | Human | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of LGALS12 mRNA | CTD | PMID:25047013 | LGALS12 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of LGALS12 mRNA | CTD | PMID:28628672 | LGALS12 | Human | dicyclanil | increases expression | ISO | Lgals12 (Mus musculus) | 6480464 | dicyclanil results in increased expression of LGALS12 mRNA | CTD | PMID:15664270 | LGALS12 | Human | dieldrin | affects expression | ISO | Lgals12 (Rattus norvegicus) | 6480464 | Dieldrin affects the expression of LGALS12 mRNA | CTD | PMID:22546817 | LGALS12 | Human | dioxygen | multiple interactions | ISO | Lgals12 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS12 mRNA | CTD | PMID:30529165 | LGALS12 | Human | ethylparaben | increases expression | EXP | | 6480464 | ethyl-p-hydroxybenzoate results in increased expression of LGALS12 mRNA | CTD | PMID:37690743 | LGALS12 | Human | fonofos | decreases methylation | EXP | | 6480464 | Fonofos results in decreased methylation of LGALS12 promoter | CTD | PMID:22847954 | LGALS12 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of LGALS12 gene | CTD | PMID:31601247 | LGALS12 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of LGALS12 mRNA | CTD | PMID:28628672 | LGALS12 | Human | lidocaine | decreases expression | ISO | Lgals12 (Rattus norvegicus) | 6480464 | Lidocaine results in decreased expression of LGALS12 mRNA | CTD | PMID:35283115 | LGALS12 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | LGALS12 | Human | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of LGALS12 mRNA | CTD | PMID:35811015 | LGALS12 | Human | parathion | decreases methylation | EXP | | 6480464 | Parathion results in decreased methylation of LGALS12 promoter | CTD | PMID:22847954 | LGALS12 | Human | potassium bromate | multiple interactions | ISO | Lgals12 (Mus musculus) | 6480464 | [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LGALS12 mRNA] | CTD | PMID:27082013 | LGALS12 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | LGALS12 | Human | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of LGALS12 mRNA | CTD | PMID:35811015 | LGALS12 | Human | sulforaphane | increases expression | EXP | | 6480464 | sulforaphane results in increased expression of LGALS12 mRNA | CTD | PMID:26833863 | LGALS12 | Human | terbufos | decreases methylation | EXP | | 6480464 | terbufos results in decreased methylation of LGALS12 promoter | CTD | PMID:22847954 | LGALS12 | Human | titanium dioxide | decreases expression | ISO | Lgals12 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of LGALS12 mRNA | CTD | PMID:23557971 | |